CLOs on the Move

Armetheon

www.armetheon.com

 
Armetheon, Inc. is a privately held San Francisco Bay area-based biopharmaceutical company with late-stage clinical drug candidates in development for cardiovascular diseases. The company was founded in 2011 by experienced biotech entrepreneurs and drug developers. Armetheon’s two late-stage small molecule drug candidates are for use in the areas of oral anti-coagulation and anti-arrhythmia for atrial fibrillation. The company was founded with the idea that drug innovations can happen by building on the success of proven medications. We create solutions that are within the same class of medication and that utilize the same mechanism of action as existing therapies. This development approach has the ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.armetheon.com
  • 3375 Scott Blvd Suite 306
    Santa Clara, CA USA 95054
  • Phone: 650.646.3898

Executives

Name Title Contact Details

Similar Companies

Woodlyn Inc

Woodlyn Inc is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Merz Aesthetics

Merz Aesthetics is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ForTec Companies

ForTec Companies is a Streetsboro, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Avinger

Avinger, Inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (PAD). PAD is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. The company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. Avinger’s current lumivascular products include the Lightbox imaging console, the Ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or CTOs, and Pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in PAD patients.

Drive Medical

Drive DeVilbiss is committed to bringing to market a superior suite of products that focuses on innovation and design while improving the quality of life and promoting the independence for the individuals that use our durable medical equipment. Drive is dedicated to their customers by continually offering the highest quality and most functional products across a broad spectrum of health care needs, products that are a better value and competitively priced delivered by a team of world-class professionals. Drive’s complete line of products enhances the life of each user, from the mobility, bariatric, pressure prevention, self-assist, rehabilitation, pediatric products, to our wheelchairs, sleep surfaces, beds, respiratory equipment, power scooters, patient room equipment, to our electrotherapy devices and personal care products. We are the fastest growing global manufacturers of durable medical equipment; our products are used and distributed throughout North America, Europe, Central America, South America, the Middle East and Asia. Our market spans many verticals including: home healthcare providers, healthcare distributors, retailers, and e-tailers. Our recent expansion includes a new Long-Term Care Division and a new Acute Care Division. These developments are accompanied by the continued growth in the core home health care business. The corporate and distribution offices extend across the United States, Canada, United Kingdom, Germany, Romania, China and Taiwan.